STUDY THAT COMPARE 3 ARM: MLN9708 DEXAMETHASONE, MLN9708 CYCLOPHOSPHAMIDE AND DEXAMETHASONE, MLN9708 THALIDOMIDE AND DEXAMETHASONE FOLLOWED BY MAINTENANCE WITH MLN9708 IN NEWLY DIAGNOSED ELDERLY MULTIPLE MYELOMA PATIENTS

NCT02586038 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

175

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: MLN9708
DRUG: Dexamethasone
DRUG: Cyclophosphamide
DRUG: Thalidomide

Sponsor

Mario Boccadoro